论文信息 - Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study - 字舞流文

Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study

A. Hiester | T. Buchler | U. Pichlmeier | M. Pichler | K. Dieckmann | A. Heidenreich | M. Mego | H. Isbarn | E. Trenti | L. Geczi | R. Pichler | P. Paffenholz | S. Krege | C. Wülfing | S. Zschäbitz | S. Vallet | G. Aurilio | M. Hentrich | C. Seidel | Matthaeus Majewski | P. Bader | Cem Aksoy | T. Nestler | J. Heinzelbecker | F. Zengerling | Tamás Dienes | D. Niedersüss-Beke | S. Schönburg | Inken Dralle-Filiz | P. Törzsök | T. Gschliesser | T. Pokrivcak | H. Študentová | P. Krausewitz | J. Ring | David Niehaus | Cord Matthies | Sandra Schönburg | C. Matthies